Other languages MacroGenics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
4.7 ^USD	+10.33%		-0.21%	-51.14%

May. 10	Sector Update: Health Care Stocks Higher Late Afternoon	MT
May. 10	Sector Update: Health Care	MT

Sector Update: Health Care Stocks Higher Late Afternoon	May. 10
Sector Update: Health Care	May. 10
Top Midday Decliners	May. 10
Sector Update: Health Care Stocks Edge Higher Premarket Friday	May. 10
Top Premarket Decliners	May. 10
MacroGenics Says Five Patients Died in Cancer Study	May. 10
MacroGenics Q1 Loss Widens, Revenue Falls	May. 10
MacroGenics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08
Sector Update: Health Care Stocks Mixed in Afternoon Trading	Apr. 04
MacroGenics Shares Surge Following Phase 2 Update on Prostate Cancer Drug	Apr. 04
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Renewed Rate Cut Hopes	Apr. 04
Sector Update: Health Care	Apr. 04
MacroGenics Says Cancer Drug Study Update Set for May After Conference Miss	Apr. 03
MacroGenics, Inc. Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures	Apr. 03
MacroGenics Narrows 2023 Net Loss, Revenue Drops; Shares Fall After-Hours	Mar. 07
MacroGenics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07
Macrogenics Insider Sold Shares Worth $813,501, According to a Recent SEC Filing	Mar. 06
Macrogenics Insider Sold Shares Worth $615,000, According to a Recent SEC Filing	Mar. 06
Macrogenics Insider Sold Shares Worth $1,258,142, According to a Recent SEC Filing	Feb. 07
Sector Update: Health Care Stocks Retreat Late Afternoon	Dec. 20

No results for this search